Ultra-Long-term Follow-up of Interferon Alfa Treatment for HBeAg-Positive Chronic Hepatitis B Virus Infection-Reference-Cited by-同舟云学术

Ultra-Long-term Follow-up of Interferon Alfa Treatment for HBeAg-Positive Chronic Hepatitis B Virus Infection

Published:2021-09 Issue:9 Volume:19 Page:1933-1940.e1
ISSN:1542-3565
Container-title:Clinical Gastroenterology and Hepatology
language:en
Short-container-title:Clinical Gastroenterology and Hepatology

Author:

Choi Hannah S.J.^ORCID,van Campenhout Margo J.H.,van Vuuren Anneke J.,Krassenburg Lisette A.P.,Sonneveld Milan J.,de Knegt Robert J.,Hansen Bettina E.,Janssen Harry L.A.

Funder

AbbVie

Fujirebio Europe

Roche

Gilead Sciences

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference27 articles.

1. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study;Razavi-Shearer;Lancet Gastroenterol Hepatol,2018

2. Endpoints of therapy in chronic hepatitis B;Feld;Hepatology,2009

3. AASLD guidelines for treatment of chronic hepatitis B;Terrault;Hepatology,2016

4. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection;Lampertico;J Hepatol,2017

5. Guidance for design and endpoints of clinical trials in chronic hepatitis B - report from the 2019 EASL-AASLD HBV Treatment Endpoints Conference;Cornberg;J Hepatol,2019

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of DNA tumor viruses in low-to-middle income countries (LMICS): A literature review;Tumour Virus Research;2024-12

2. Quantitative hepatitis B core antibody and quantitative hepatitis B surface antigen: Novel viral biomarkers for chronic hepatitis B management;World Journal of Hepatology;2024-04-27

3. Relationship between Phenotypic Changes of Dendritic Cell Subsets and the Onset of Plateau Phase during Intermittent Interferon Therapy in Patients with CHB;BIOMED ENVIRON SCI;2024

4. Mechanism of interferon alpha therapy for chronic hepatitis B and potential approaches to improve its therapeutic efficacy;Antiviral Research;2024-01

5. A novel TRIM22 gene polymorphism promotes the response to PegIFNα therapy through cytokine-cytokine receptor interaction signaling pathway in chronic hepatitis B;Microbiology Spectrum;2023-12-12